Lv11
41 积分 2021-08-11 加入
The Critical Need for Implementing RRF in the Accurate Assessment of Impurities in Peptide Therapeutics
7小时前
待确认
Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs
7小时前
已完结
A Review on Forced Degradation Strategies to Establish the Stability of Therapeutic Peptide Formulations
7小时前
已完结
Back to therapeutic modality basics
2个月前
已关闭
Reproductive and developmental toxicity assessment of HSK21542, a novel peripherally-restricted kappa opioid receptor agonist in rats and rabbits
3个月前
已完结
The promise of microneedle technologies for drug delivery
3个月前
已完结
Reactivity of N terminal Histidine of Peptides towards Excipients/Impurity of Excipients: A Case Study of Liraglutide Excipient Compatibility Study
3个月前
已完结
Breaking the impossible: The evolutionary journey of lenacapavir, a long-acting anti-HIV drug
3个月前
已完结
The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue
5个月前
已完结
The landscape of small-molecule prodrugs
1年前
已完结
皖公网安备34019202002308
